Golovchenko S - Search Results

1

Dual pathways to endochondral osteoblasts: a novel chondrocyte-derived osteoprogenitor cell identified in hypertrophic cartilage.

Park J, Gebhardt M, Golovchenko S, Perez-Branguli F, Hattori T, Hartmann C, Zhou X, deCrombrugghe B, Stock M, Schneider H, von der Mark K. Park J, et al. Among authors: golovchenko s. Biol Open. 2015 Apr 16;4(5):608-21. doi: 10.1242/bio.201411031. Biol Open. 2015. PMID: 25882555 Free PMC article.

2

Deletion of beta catenin in hypertrophic growth plate chondrocytes impairs trabecular bone formation.

Golovchenko S, Hattori T, Hartmann C, Gebhardt M, Gebhard S, Hess A, Pausch F, Schlund B, von der Mark K. Golovchenko S, et al. Bone. 2013 Jul;55(1):102-12. doi: 10.1016/j.bone.2013.03.019. Epub 2013 Apr 6. Bone. 2013. PMID: 23567158

3

[Organ Bath Experiments on Human Pulmonary Vessels: Assessment of Drug Efficacy for Treatment of Pulmonary Arterial Hypertension].

Stadlbauer C, Golovchenko S, Englert L, Spaeth M, Hoenicka M, Hofmann HS, Ried M. Stadlbauer C, et al. Among authors: golovchenko s. Pneumologie. 2021 May;75(5):369-376. doi: 10.1055/a-1332-6892. Epub 2021 Jan 20. Pneumologie. 2021. PMID: 33472251 Free article. German.

4

Evaluation of the combination of endothelin receptor antagonists (ERA) and phosphodiesterase-5 inhibitors for the treatment of pulmonary arterial hypertension (PAH) in pathologic human pulmonary arteries in an ex-vivo organ bath model.

Englert L, Stadlbauer C, Spaeth M, Hofmann HS, Schneider C, Hatz RA, Preissler G, Michel S, Golovchenko S, Ried M, Hoenicka M. Englert L, et al. Among authors: golovchenko s. Pulm Pharmacol Ther. 2021 Feb;66:101985. doi: 10.1016/j.pupt.2020.101985. Epub 2020 Dec 24. Pulm Pharmacol Ther. 2021. PMID: 33359621

5

Combination Therapy of Pulmonary Arterial Hypertension with Vardenafil and Macitentan Assessed in a Human Ex Vivo Model.

Hoenicka M, Golovchenko S, Englert L, Spaeth M, Shoshiashvili L, Großer C, Hofmann HS, Ried M. Hoenicka M, et al. Among authors: golovchenko s. Cardiovasc Drugs Ther. 2019 Jun;33(3):287-295. doi: 10.1007/s10557-019-06868-y. Cardiovasc Drugs Ther. 2019. PMID: 30826900

6

Antioxidants as antiarrhythmic drugs.

Frolkis VV, Frolkis RA, Dubur GYa, Khmelevsky YuV, Shevchuk VG, Golovchenko SF, Mkhitarjan LS, Voronkov GS, Tsyomik VA, Lysenko IV, et al. Frolkis VV, et al. Among authors: golovchenko sf. Cardiology. 1987;74(2):124-32. doi: 10.1159/000174186. Cardiology. 1987. PMID: 3568051

7

[Anti-arrhythmic action of preparations of the dihydropyridine series].

Frol'kis VV, Frol'kis RA, Dubur GIa, Golovchenko SF, Shevchuk VG. Frol'kis VV, et al. Among authors: golovchenko sf. Farmakol Toksikol. 1983 Nov-Dec;46(6):20-4. Farmakol Toksikol. 1983. PMID: 6653752 Russian.

8

[The effect of pain stress in rats of various ages on vasopressin sensitivity of the smooth muscles of the aorta].

Golovchenko SF. Golovchenko SF. Fiziol Zh (1978). 1983 May-Jun;29(3):340-5. Fiziol Zh (1978). 1983. PMID: 6873337 Russian. No abstract available.

9

[Vasopressin and the cardiovascular system].

Frol'kis VV, Golovchenko SF, Medved' VI, Frol'kis RA. Frol'kis VV, et al. Among authors: golovchenko sf. Usp Fiziol Nauk. 1983 Apr-Jun;14(2):56-81. Usp Fiziol Nauk. 1983. PMID: 6344484 Review. Russian. No abstract available.

10

Vasopressin and cardiovascular system in aging.

Frolkis VV, Golovchenko SF, Medved VI, Frolkis RA. Frolkis VV, et al. Among authors: golovchenko sf. Gerontology. 1982;28(5):290-302. doi: 10.1159/000212546. Gerontology. 1982. PMID: 6922818

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

23 results

Search Page

Filters